73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
ePoster Montag, 30.05.2022
Experimentelle Neuroonkologie I/Experimental Neurooncology I
Meeting Abstract
(P048)
[Full Text]
Ex vivo expanded, autologous NKG2C+ natural killer cells from blood of HCMV+ patients for immunotherapy of glioblastoma multiforme
Michen S, Sagerer ANJ, Jugel W, Becker A, Füssel M, Schackert G, Temme A[Full Text]
Meeting Abstract
(P049)
[Full Text]
Activation of the CCR8-ACP5 axis by human, microglia/macrophage derived CCL18 promotes glioma growth
Huang Y, Motta E, Nanvuma C, Kuhrt L, Yuan Y, Xia P, Lubas M, Zhu S, Quazi N, Hu F, Zhang H, Ting L, Synowitz M, Kettenmann H, Flüh C[Full Text]
Meeting Abstract
(P051)
[Full Text]
The antineoplastic effect of antiepileptic drugs in patient-derived IDH mutant glioma stem cells
Dao Trong HP, Jungwirth G, Warta R, Unterberg AW, Herold-Mende C[Full Text]
Meeting Abstract
(P052)
[Full Text]
Expression of E1 components of mitochondrial 2-Oxo-Dehydrogenase complexes as prognostic markers, indicators of malignancy and potential therapeutic targets
Kölling T, Seidenstücker T, Meixensberger J, Gaunitz F[Full Text]
Meeting Abstract
(P053)
[Full Text]
Expression of potential tumour promoter LRIG2 is higher in secondary glioblastoma than in primary glioblastomas
Happe M, Goldbrunner R, Timmer M[Full Text]
Meeting Abstract
(P054)
[Full Text]
ENO1 is upregulated in relapsed low-grade glioma
Dinh TD, Goldbrunner R, Timmer M[Full Text]
Meeting Abstract
(P055)
[Full Text]
Concomitant application of Tumour Treating Fields (TTFields), temozolomide and lomustine in glioblastoma cancer cells in vitro suggests efficacy benefit
Fishman H, Monin R, Dor-On E, Haber A, Ehrle S, Giladi M, Weinberg U, Palti Y[Full Text]
Meeting Abstract
(P057)
[Full Text]
Riluzole effect on dexamethasone induced expression of stemness related marker in U87MG cells
Keul J, Sperling S, Ninkovic M, Rohde V[Full Text]
Meeting Abstract
(P058)
[Full Text]
A target therapy approach for BRAF mutant Glioblastoma with human preclinical glioblastoma model
Zhang J, Ravi VM, Joseph K, Beck J, Schnell O, Heiland DH[Full Text]
Meeting Abstract
(P059)
[Full Text]
Insights into gene regulation under temozolomide-promoted cellular dormancy and its connection to stemness
Kubelt C, Hellmold D, Ahmeti H, Synowitz M, Held-Feindt J[Full Text]